My
research focuses on the general area of
protein-lipid interactions. It has been estimated that over one-third
of mammalian genes code for transmembrane or membrane associated
proteins. Transmembrane proteins often serve as signal receptors and
transducers for the cell, making them a hot target in pharmaceutical
research. A number of proteins also transition from completely
water-soluble forms to conformations that interact with lipid
membranes. These include a number of bacterial toxins, cellular signal
transduction molecules, and antimicrobial peptides. My research
interests can be broken down in two major subdivisions, outlined below.
Antimicrobial Peptides:
AMPs are short, naturally occurring peptides that
demonstrate broad spectrum bacteriocidal (killing bacteria) or
bacteriostatic (stopping bacterial growth) properties. These peptides
are found in most higher organisms and play a front-line role in the
innate immune system. AMPs are typically 10-50 amino acids in length
and are often unstructured until they interact with a target membrane,
at which point they will often
adopt an alpha-helical structure. The
peptides are typically amphipathic helices with positively charged
amino acids on one face of the helix and hydrophobic amino acids
localizing to the opposite site of the helix. The mechanism by which
these peptides act is currently a hot debate. Many AMPs have been shown
to cause permeabilization of bacterial cell membranes which, in turn,
leads to the bacterium's inability to generate ATP and therefore
results in death. However, it has been demonstrated that these peptides
can cause killing or bacteriostasis at much lower levels than are
required for membrane permeabilization. Through transcriptional
profiling experiments it was shown that a variety of genes and aberrant
gene responses were a result of very low levels of exposure to AMPs.
My research focuses on understanding what about these peptides make
them
(a) broad spectrum, (b) membrane permeabilizing, and (c) signaling
activators. The initial phase of the investigation is focusing on the
amino acid identities in the peptides. Naturally ocurring AMPs are
limited to the 20 natural proteinogenic amino acids which limits and
restricts the potential interactions. Changing the amino acid sequence
to affect the physiochemical properties of the peptide as well as
incorporating non-native
amino acids through solid-phase synthesis
methods will garner a more thorough understanding of which peptide
properties play a role in which mechanisms of action. We use a
combination of biochemical, bacteriological, and biophysical techniques
to assay peptide activity. We are also interested in the
lipid-mediated effects of peptide-membrane interactions.
Specifically, since the lipid composition of the
bacterial membrane is vastly different from that of a mammalian
cell membrane we are investigating which lipid components are involved
in each stage of the AMP interaction with the bacterial cell.
Transmembrane Peptides:
Over one-third (~33%) of all proteins in higher organisms are expected
to be
transmembrane or membrane associated proteins but approximately
two-thirds (~67%) of all pharmaceutical drug-targets. These proteins
can act as enzymes, channels, pores, pumps, and signal receptors.
While we know that the most common
secondary structural motif in transmembrane proteins is the
alpha-helix, there is much less high resolution str
uctural information
available for
membrane proteins due to a variety of complicating experimental factros
stemming from their hydrophobicity and difficulty in high yield
expression methods. To overcome some of these restrictions, short
peptides that mimic a transmembrane helix have been very successfully
applied to study the behavior and dynamics of TM alpha helices. These
peptides can be model systems to understand the basics of behavior in
the membrane, or they can be sequence mimcs of natural TM sequences.
My research in this area focuses on understanding what properties of
these peptides are most important for determining their ability to form
a TM helix. Natural TM helices have a variety of primary sequences, not
all of which are hydrophobic residues. We'd like to learn more about
how specific amino acids affect the equilibrium between transmembrane
and non-transmembrane orientations. Specifically, we're interested in
how the number and location in the helix of non-hydrophobic amino acids
such as Asp, Lys, and other non proteinogenic amino acids (Dap, Orn,
etc) affect this equilibrium. These amino acids can be charged or
uncharged, depending on their location and the pH of the environment.
We incorporate peptides containing these amino acids of interest into
lipid vesicles to investigate their properties. How this ionization
event affects their membrane topology is one of the basic questions in
this area. The methodology we employ is based on
physical methods (cysteine crosslinking, disulfide bond formation) and
spectroscopic techniques including fluorescence spectroscopy,
fluorescence quenching, and circular dichroism.
home